Table 5.
Estimate of half-lives (in years) of PCB grouping and specific congeners, p,p′-DDE, and HCB.
| Model 1* Unadjusted Half-life | Model 2** Adjusted Half-life | Model 3*** Adjusted Half-life LR Method (all cases) | Model 4**** Adjusted Half-life LR Method (no increase cases) | |
|---|---|---|---|---|
|
| ||||
| Mean | Mean | Mean | Mean | |
|
| ||||
| Σ16PCB50%a | 8.4 | 7.91 | 6.64 | 5.15 |
| Σ8PerPCBsb | 12.54 | 13.19 | 10.35 | 6.18 |
| Σ6NONPerPCBsc | 5.46 | 4.5 | 4.08 | 3.5 |
| p,p′-DDE | 35.62 | 55.78 | 20.9 | 7.2 |
| HCB | 69.52 | 84.74 | 73.45 | 8.67 |
|
| ||||
| PCB IUPAC#a
| ||||
| 105 | 8.43 | 7.19 | 4.47 | 2.36 |
| 118 | 7.68 | 6.49 | 5.4 | 3.71 |
| 138 [+163+164]d | 22.32 | 24.67 | 27.75 | 5.82 |
| 153 | 14.13 | 16.32 | 13.18 | 5.55 |
Half-life estimated with Tobit regression without adjusting for any covariates
Half-life estimated with Tobit regression adjusted for vectors of intake and controls
Half-life estimated with linear regression (LR) using all respondents (adjusted for vectors of intake and controls)
Half-life estimated with linear regression (LR) eliminating respondents with increased POP level (adjusted for vectors of intake and controls)
Congeners with ≥ 50% detection rate in MAWBs: IUPAC #s: 52, 70, 74, 84, 87, 95, 99, 101[+90], 105, 110, 118, 149[+123], 138[+163+164], 153, 180, 187
Sum of IUPAC#s: 74, 99, 105, 118, 138[+163+164], 153, 180, 187
Sum of IUPAC#s: 52,84,95,101,110,123[+149]
Bracket indicates ‘minor’ congener based on aroclor concentration (Hansen, 1999)